Alimentiv Inc.

12 clinical trials · Sponsor

Record	Firm	Date
Open-label Single-arm Study to Assess the Efficacy of Mirikizumab in Patients With Inflammatory Strictures Due to CD (NCT06997965)	Alimentiv Inc.	2026-04-20
A Prospective Randomised Study of Treatment Selection Based on Epigenetic Markers Versus Standard of Care Treatment Selection in Adults With CROHN's Disease (NCT07363044)	Alimentiv Inc.	2025-02-01
VECTORS - A Study to Evaluate Transmural Healing as a Treatment Target in Crohn's Disease (NCT06257706)	Alimentiv Inc.	2024-08-07
Development of a Novel Endoscopic Index and Patient-reported Outcome Measure for Clinical Trials in Participants With Permanent Ileostomy (NCT06670638)	Alimentiv Inc.	2024-06-19
VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study (NCT06249555)	Alimentiv Inc.	2024-03-20
Assessment of Patients With Acute Pouchitis Treated With Antibiotics (NCT05252273)	Alimentiv Inc.	2021-12-07
Identification of Biomarkers of Janus Kinase Inhibitor Therapy in Patients With Ulcerative Colitis (NCT04576000)	Alimentiv Inc.	2020-08-25
Determination of the Optimal Treatment Target in Ulcerative Colitis (NCT04259138)	Alimentiv Inc.	2020-02-18
Stopping Aminosalicylate Therapy in Inactive Crohn's Disease (NCT03261206)	Alimentiv Inc.	2017-11-20

Every clearance here is in the API, with alerts when new ones post.